Clincosm LogoSign in Get a demo

Tuberculosis

Showing 26 - 50 of 743
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial in Lincoln (MK-7762 (TBD09), Placebo)

Recruiting
  • Tuberculosis
  • MK-7762 (TBD09)
  • Placebo
  • Lincoln, Nebraska
    Investigational Site
Apr 11, 2023

Tuberculosis Trial (Intradermal BCG (bacillus calmette-guerin) vaccine AJV)

Not yet recruiting
  • Tuberculosis
  • Intradermal BCG (bacillus calmette-guerin) vaccine AJV
  • (no location specified)
Apr 17, 2023

Diagnosis, Tuberculosis, geneXpert Trial in Wolisso, Oromia (Diagnosis of Tuberculosis with computer-aided detection (CAD)

Not yet recruiting
  • Diagnosis
  • +2 more
  • Diagnosis of Tuberculosis with computer-aided detection (CAD) software
  • Wolisso, Oromia, Ethiopia
    St Luke Hospital
Apr 14, 2023

KAP Regarding Tuberculosis Among Physicians in Assiut City

Not yet recruiting
  • Tuberculosis
    • (no location specified)
    Apr 6, 2023

    Latent Tuberculosis Infection in Health-care Workers and

    Recruiting
    • Tuberculosis
    • +4 more
    • Prevalence of Latent Tuberculosis Infection
    • Roma, Italy
      UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico
    Mar 1, 2023

    Lung Cancer, Tuberculosis, Pneumonia Trial in Russian Federation (Virtual bronchoscopy navigation, radial EBUS)

    Recruiting
    • Lung Cancer
    • +2 more
    • Virtual bronchoscopy navigation
    • radial EBUS
    • Chelyabinsk, Russian Federation
    • +5 more
    Feb 13, 2023

    Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)

    Recruiting
    • Tuberculosis
    • +2 more
    • N acetyl cysteine
    • Bangkok, Thailand
      Faculty of Medicine, Siriraj Hospital
    Feb 12, 2023

    CD4/CD8+ Interferon Gamma Release Assay for Monitoring

    Active, not recruiting
    • Tuberculosis
    • Interferon gamma release assay (IGRA)
    • Milano, Italy
      IRCCS San Raffaele Scientific Institute
    Feb 13, 2023

    HIV Seropositivity, Tuberculosis, Household Contact Trial in Klerksdorp (Daily rifapentine and isoniazid for 4 weeks, Weekly

    Not yet recruiting
    • HIV Seropositivity
    • +2 more
    • Daily rifapentine and isoniazid for 4 weeks
    • Weekly rifapentine and isoniazid for 12 weeks
    • Klerksdorp, North West Province, South Africa
      The Aurum Institute: Gavin J Churchyard Legacy Centre
    Jan 31, 2023

    Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET

    Recruiting
    • Tuberculosis
    • 18F-Pretomanid PET/CT
    • Baltimore, Maryland
      Johns Hopkins Medical Institutions
    Jan 30, 2023

    Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

    Recruiting
    • Tuberculosis
    • Cape Town, South Africa
      GSK Investigational Site
    Jan 24, 2023

    HIV/AIDS, Transitions of Care, Hospitalization Trial in Lusaka (Inpatient lab bundling, Inpatient navigation)

    Recruiting
    • HIV/AIDS
    • +5 more
    • Inpatient lab bundling
    • Inpatient navigation
    • Lusaka, Zambia
      University Teaching Hospital
    Jan 20, 2023

    Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

    Not yet recruiting
    • Tuberculosis
    • BNT164a1
    • +2 more
    • (no location specified)
    Jan 18, 2023

    Methods in People Living With Retroviral Infection in Liberia

    Active, not recruiting
    • Tuberculosis
    • HIV
      • Bethesda, Maryland
      • +4 more
      Jan 14, 2023

      Tuberculosis Trial in Mozambique, South Africa, Tanzania (Sutezolid, N-acetyl cysteine, Pretomanid)

      Not yet recruiting
      • Tuberculosis
      • Maputo, Mozambique
      • +3 more
      Jan 13, 2023

      Worse Outcome Post-Sars-CoV-2 Infection

      Completed
      • COVID-19
      • +2 more
        • Johannesburg, Gauteng, South Africa
          The Aurum Institute
        Jan 9, 2023

        Sputum DNA Testing for Lung Cancer in China

        Recruiting
        • Lung Cancer
        • +15 more
        • Diagnostic Test: Sputum DNA methylation analysis
        • chest CT or pathological examination
        • Guangzhou, Guangdong, China
          Nanfang Hospital of Southern Medccal University
        Dec 29, 2022

        Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

        Recruiting
        • Tuberculosis
        • +2 more
        • Observational PK study
        • Kumasi, Ghana
          Kwame Nkrumah University of Science and Technology
        Dec 21, 2022

        Tuberculosis Trial in H?i Phòng (Community based TB intervention)

        Not yet recruiting
        • Tuberculosis
        • Community based TB intervention
        • Hải Phòng, Vietnam
        • +1 more
        Dec 15, 2022

        Tuberculosis Trial in Mbarara (SMS texts + incentives + Wisepill device for medication monitoring, SMS texts only + Wisepill

        Recruiting
        • Tuberculosis
        • SMS texts + incentives + Wisepill device for medication monitoring
        • +2 more
        • Mbarara, Uganda
          Mbarara Regional Referral Hospital
        Dec 15, 2022

        Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

        Recruiting
        • Tuberculosis, Multidrug-Resistant
        • +2 more
        • Linezolid 600 mg
        • +7 more
        • Gaborone, South-East District, Botswana
        • +16 more
        Dec 13, 2022

        Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)

        Active, not recruiting
        • Tuberculosis
        • Seattle, Washington
          Fred Hutchinson Cancer Center
        Dec 9, 2022

        Tuberculosis, HIV Trial (Dolutegravir, 3HP)

        Not yet recruiting
        • Tuberculosis
        • HIV
        • (no location specified)
        Dec 9, 2022

        Tuberculosis Trial in Worldwide (FLOW-TB Next-generation LAM, TAM-TB, Host Response Cartridge)

        Recruiting
        • Tuberculosis
        • FLOW-TB Next-generation LAM
        • +13 more
        • Vellore, India
        • +10 more
        Dec 8, 2022

        Tuberculosis, Tuberculosis, Pulmonary Trial in Kampala (User-Centered Implementation Strategy, Standard Implementation Strategy)

        Enrolling by invitation
        • Tuberculosis
        • Tuberculosis, Pulmonary
        • User-Centered Implementation Strategy
        • Standard Implementation Strategy
        • Kampala, Uganda
          Uganda Tuberculosis Implementation Research Consortium
        Nov 28, 2022